{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:53:23Z","timestamp":1770749603366,"version":"3.50.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovation Project of Guangxi Graduate Education","award":["YCBZ2025116"],"award-info":[{"award-number":["YCBZ2025116"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05518-0","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:15:55Z","timestamp":1768446955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Suboptimal lipid management is associated with subclinical left ventricular dysfunction in type 2 diabetes mellitus patients with preserved ejection fraction: a cardiac magnetic resonance feature-tracking study"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhi-ming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-chun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-qiu","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ling","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"5518_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20:685\u201395. https:\/\/doi.org\/10.1038\/s41569-023-00877-z.","journal-title":"Nat Rev Cardiol"},{"key":"5518_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4239\/wjd.v10.i5.280","volume":"10","author":"I Jialal","year":"2019","unstructured":"Jialal I, Singh G. Management of diabetic dyslipidemia: an update. World J Diabetes. 2019;10:280\u201390. https:\/\/doi.org\/10.4239\/wjd.v10.i5.280.","journal-title":"World J Diabetes"},{"key":"5518_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","volume":"7","author":"R Taylor","year":"2019","unstructured":"Taylor R, Al-Mrabeh A, Sattar N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 2019;7:726\u201336. https:\/\/doi.org\/10.1016\/S2213-8587(19)30076-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5518_CR4","doi-asserted-by":"publisher","first-page":"111421","DOI":"10.1016\/j.cbi.2025.111421","volume":"411","author":"X Wang","year":"2025","unstructured":"Wang X, Tan X, Zhang T, Xu S, Zeng Y, Xu A, et al. Modeling diabetic cardiomyopathy using human cardiac organoids: effects of high glucose and lipid conditions. Chem Biol Interact. 2025;411:111421. https:\/\/doi.org\/10.1016\/j.cbi.2025.111421.","journal-title":"Chem Biol Interact"},{"key":"5518_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/jcdd11050140","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Li G, Laukkanen JA, Wei L, Chen X, Higher, LDL-C\/HDL-C. Ratio is associated with elevated HbA1c and decreased eGFR levels and cardiac remodeling in elderly with hypercholesterolemia. J Cardiovasc Dev Dis. 2024;11:140. https:\/\/doi.org\/10.3390\/jcdd11050140.","journal-title":"J Cardiovasc Dev Dis"},{"key":"5518_CR6","doi-asserted-by":"publisher","unstructured":"Borlaug BA, Jensen MD, Kitzman DW, Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023;118(18):3434\u20133450. https:\/\/doi.org\/10.1093\/cvr\/cvac120. PMID: 35880317.:0\u201379. https:\/\/doi.org\/10.1093\/cvr\/cvac120.","DOI":"10.1093\/cvr\/cvac120"},{"key":"5518_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.eprac.2025.03.011","volume":"31","author":"Y Tsushima","year":"2025","unstructured":"Tsushima Y, Hatipoglu B. Diabetes and lipids: a review and update on lipid biomarkers and cardiovascular risk. Endocr Pract. 2025;31:677\u201385. https:\/\/doi.org\/10.1016\/j.eprac.2025.03.011.","journal-title":"Endocr Pract"},{"key":"5518_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(24)00537-3","volume":"404","author":"AI Adler","year":"2024","unstructured":"Adler AI, Coleman RL, Leal J, Whiteley WN, Clarke P, Holman RR. Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91). Lancet. 2024;404:145\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(24)00537-3.","journal-title":"Lancet"},{"key":"5518_CR9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.7326\/M23-0442","volume":"176","author":"VW Zhong","year":"2023","unstructured":"Zhong VW, Yu D, Zhao L, Yang Y, Li X, Li Y, et al. Achievement of Guideline-Recommended targets in diabetes care in china: A nationwide Cross-Sectional study. Ann Intern Med. 2023;176:1037\u201346. https:\/\/doi.org\/10.7326\/M23-0442.","journal-title":"Ann Intern Med"},{"key":"5518_CR10","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1503\/cmaj.220673","volume":"195","author":"S Nandiwada","year":"2023","unstructured":"Nandiwada S, Manca DP, Yeung RO, Lau D. Achievement of treatment targets among patients with type 2 diabetes in 2015 and 2020 in Canadian primary care. Can Med Assoc J. 2023;195:E1\u20139. https:\/\/doi.org\/10.1503\/cmaj.220673.","journal-title":"Can Med Assoc J"},{"key":"5518_CR11","doi-asserted-by":"publisher","unstructured":"Mach F, Koskinas KC, Van Roeters JE, Tokg\u00f6zo\u011flu L, Badimon L, Baigent C, et al. 2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2025;ehaf190. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf190.","DOI":"10.1093\/eurheartj\/ehaf190"},{"key":"5518_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-020-01138-w","volume":"19","author":"X-M Li","year":"2020","unstructured":"Li X-M, Jiang L, Guo Y-K, Ren Y, Han P-L, Peng L-Q, et al. The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study. Cardiovasc Diabetol. 2020;19:161. https:\/\/doi.org\/10.1186\/s12933-020-01138-w.","journal-title":"Cardiovasc Diabetol"},{"key":"5518_CR13","doi-asserted-by":"publisher","first-page":"11148","DOI":"10.1038\/s41598-019-46755-y","volume":"9","author":"B Hu","year":"2019","unstructured":"Hu B, Wang J, Yang Z, Ren Y, Jiang L, Xie L, et al. Cardiac magnetic resonance feature tracking for quantifying right ventricular deformation in type 2 diabetes mellitus patients. Sci Rep. 2019;9:11148. https:\/\/doi.org\/10.1038\/s41598-019-46755-y.","journal-title":"Sci Rep"},{"key":"5518_CR14","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1093\/eurheartj\/ehad510","volume":"44","author":"DC Benz","year":"2023","unstructured":"Benz DC, Gr\u00e4ni C, Antiochos P, Heydari B, Gissler MC, Ge Y, et al. Cardiac magnetic resonance biomarkers as surrogate endpoints in cardiovascular trials for myocardial diseases. Eur Heart J. 2023;44:4738\u201347. https:\/\/doi.org\/10.1093\/eurheartj\/ehad510.","journal-title":"Eur Heart J"},{"key":"5518_CR15","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/ijms26041407","volume":"26","author":"S Liu","year":"2025","unstructured":"Liu S, Laghzali O, Shalikar S, Rusu M-C, Carrier L, Niendorf T, et al. Cardiac MRI strain as an early indicator of myocardial dysfunction in hypertrophic cardiomyopathy. Int J Mol Sci. 2025;26:1407. https:\/\/doi.org\/10.3390\/ijms26041407.","journal-title":"Int J Mol Sci"},{"key":"5518_CR16","doi-asserted-by":"publisher","first-page":"e064541","DOI":"10.1136\/bmjopen-2022-064541","volume":"13","author":"CL Morgan","year":"2023","unstructured":"Morgan CL, Durand A, McCormack T, Hughes E, Berni TR, Lahoz R. Risk of major adverse cardiovascular events associated with elevated low-density lipoprotein cholesterol in a population with atherosclerotic cardiovascular disease with and without type 2 diabetes: a UK database analysis using the clinical practice research datalink. BMJ OPEN. 2023;13:e064541. https:\/\/doi.org\/10.1136\/bmjopen-2022-064541.","journal-title":"BMJ OPEN"},{"key":"5518_CR17","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47 Supplement1","author":"NA ElSayed","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee, ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, et al. 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care. 2024;47 Supplement1:S20\u201342. https:\/\/doi.org\/10.2337\/dc24-S002.","journal-title":"Diabetes Care"},{"key":"5518_CR18","doi-asserted-by":"publisher","unstructured":"Newman CB, Blaha MJ, Boord JB, Cariou B, Chait A, Fein HG, Ginsberg HN, Goldberg IJ, Murad MH, Subramanian S, Tannock LR. Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2020;105:12. https:\/\/doi.org\/10.1210\/clinem\/dgaa674.","DOI":"10.1210\/clinem\/dgaa674"},{"key":"5518_CR19","doi-asserted-by":"publisher","unstructured":"Joint Committee on the Chinese Guidelines for Lipid Management.Chinese guidelines for lipid management. (2023).Chin J Cardiol, March 2023, Vol. 51, No. 3.https:\/\/doi.org\/10.3760\/cma.j.cn112148-20230119-00038","DOI":"10.3760\/cma.j.cn112148-20230119-00038"},{"key":"5518_CR20","unstructured":"Endocrinology and Metabolism Physician Branch of Chinese Medical Doctor Association. National Society of Cardiometabolic Medicine.Expert consensus on the lipid management of diabetic patients (2024 edition).Chin J Diabetes Mellitus, April 2024, Vol. 16, No. 4.DOI: 10. 3760\/cma.j.cn115791-20240301-00090."},{"key":"5518_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12968-021-00827-z","volume":"24","author":"WG Hundley","year":"2022","unstructured":"Hundley WG, Bluemke DA, Bogaert J, Flamm SD, Fontana M, Friedrich MG, et al. Society for cardiovascular magnetic resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson. 2022;24:29\u201355. https:\/\/doi.org\/10.1186\/s12968-021-00827-z.","journal-title":"J Cardiovasc Magn Reson"},{"key":"5518_CR22","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1001\/jama.2024.13946","volume":"332","author":"C Eichhorn","year":"2024","unstructured":"Eichhorn C, Koeckerling D, Reddy RK, Ardissino M, Rogowski M, Coles B, et al. Risk stratification in nonischemic dilated cardiomyopathy using CMR imaging: a systematic review and meta-analysis. JAMA. 2024;332:1535. https:\/\/doi.org\/10.1001\/jama.2024.13946.","journal-title":"JAMA"},{"key":"5518_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/00015385.2020.1742455","volume":"76","author":"MP Hermans","year":"2021","unstructured":"Hermans MP, Ahn SA, Rousseau MF. Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC\/EAS 2019 guidelines. Acta Cardiol. 2021;76:375\u201383. https:\/\/doi.org\/10.1080\/00015385.2020.1742455.","journal-title":"Acta Cardiol"},{"key":"5518_CR24","doi-asserted-by":"publisher","first-page":"117313","DOI":"10.1016\/j.atherosclerosis.2023.117313","volume":"394","author":"A Chait","year":"2024","unstructured":"Chait A, Eckel RH, Vrablik M, Zambon A. Lipid-lowering in diabetes: an update. Atherosclerosis. 2024;394:117313. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117313.","journal-title":"Atherosclerosis"},{"key":"5518_CR25","doi-asserted-by":"publisher","unstructured":"Kanagala A, J MH. Metabolic dysregulation and its multifaceted impact on cardiovascular autonomic control in type 2 diabetes mellitus: insights from comprehensive assessment. Cureus. 2024;0\u20137. https:\/\/doi.org\/10.7759\/cureus.59776.","DOI":"10.7759\/cureus.59776"},{"key":"5518_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yjmcc.2025.02.010","volume":"201","author":"TVT Luong","year":"2025","unstructured":"Luong TVT, Yang S, Kim J. Lipotoxicity as a therapeutic target in the type 2 diabetic heart. J Mol Cell Cardiol. 2025;201:105\u201321. https:\/\/doi.org\/10.1016\/j.yjmcc.2025.02.010.","journal-title":"J Mol Cell Cardiol"},{"key":"5518_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12933-024-02304-0","volume":"23","author":"Y-N Jiang","year":"2024","unstructured":"Jiang Y-N, Gao Y, Zhang Y-S, Min C-Y, Shen L-T, Yan W-F, et al. Aggravating effect of abnormal low-density protein cholesterol level on coronary atherosclerotic plaque in type 2 diabetes mellitus patients assessed by coronary computed tomography angiography. Cardiovasc Diabetol. 2024;23:234. https:\/\/doi.org\/10.1186\/s12933-024-02304-0.","journal-title":"Cardiovasc Diabetol"},{"key":"5518_CR28","doi-asserted-by":"publisher","first-page":"103184","DOI":"10.1016\/j.redox.2024.103184","volume":"73","author":"M Wu","year":"2024","unstructured":"Wu M, Tan J, Cao Z, Cai Y, Huang Z, Chen Z, et al. Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation. Redox Biol. 2024;73:103184. https:\/\/doi.org\/10.1016\/j.redox.2024.103184.","journal-title":"Redox Biol"},{"key":"5518_CR29","doi-asserted-by":"publisher","first-page":"e14965","DOI":"10.1111\/jch.14965","volume":"27","author":"S Zhang","year":"2025","unstructured":"Zhang S, Yang Y, Chen X, Fan L, Wu J, Liu X, et al. Diabetes mellitus and hyperlipidemia status among hypertensive patients in the community and influencing factors analysis of blood pressure control. J Clin Hypertens. 2025;27:e14965. https:\/\/doi.org\/10.1111\/jch.14965.","journal-title":"J Clin Hypertens"},{"key":"5518_CR30","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/ijms23073587","volume":"23","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Miyoshi T, Yoshida M, Akagi S, Saito Y, Ejiri K, et al. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci. 2022;23:3587. https:\/\/doi.org\/10.3390\/ijms23073587.","journal-title":"Int J Mol Sci"},{"key":"5518_CR31","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1056\/NEJMoa2200436","volume":"387","author":"The GRADE Study Research Group","year":"2022","unstructured":"The GRADE Study Research Group. Glycemia reduction in type 2 diabetes \u2014 microvascular and cardiovascular outcomes. N Engl J Med. 2022;387:1075\u201388. https:\/\/doi.org\/10.1056\/NEJMoa2200436.","journal-title":"N Engl J Med"},{"key":"5518_CR32","doi-asserted-by":"publisher","first-page":"107975","DOI":"10.1016\/j.pharmthera.2021.107975","volume":"231","author":"JA McClung","year":"2022","unstructured":"McClung JA, Levy L, Garcia V, Stec DE, Peterson SJ, Abraham NG. Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: therapeutic implications. Pharmacol Ther. 2022;231:107975. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107975.","journal-title":"Pharmacol Ther"},{"key":"5518_CR33","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1111\/bph.70035","volume":"182","author":"W Chen","year":"2025","unstructured":"Chen W, Jin T, Xie Y, Zhong C, Gao H, Zhang L, et al. Berberine partially ameliorates cardiolipotoxicity in diabetic cardiomyopathy by modulating SIRT3-mediated lipophagy to remodel lipid droplets homeostasis. Br J Pharmacol. 2025;182:5038\u201356. https:\/\/doi.org\/10.1111\/bph.70035.","journal-title":"Br J Pharmacol"},{"key":"5518_CR34","doi-asserted-by":"publisher","first-page":"1365169","DOI":"10.3389\/fendo.2024.1365169","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Chen C, Zheng L, Cheng W, Bu X, Liu Z. Assessment of new-onset heart failure prediction in a diabetic population using left ventricular global strain: a prospective cohort study based on UK biobank. Front Endocrinol. 2024;15:1365169. https:\/\/doi.org\/10.3389\/fendo.2024.1365169.","journal-title":"Front Endocrinol"},{"key":"5518_CR35","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1007\/s00330-024-10658-y","volume":"34","author":"W Yang","year":"2024","unstructured":"Yang W, Zhu L, He J, Wu W, Zhang Y, Zhuang B, et al. Long-term outcomes prediction in diabetic heart failure with preserved ejection fraction by cardiac MRI. Eur Radiol. 2024;34:5678\u201390. https:\/\/doi.org\/10.1007\/s00330-024-10658-y.","journal-title":"Eur Radiol"},{"key":"5518_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.33963\/KP.a2023.0030","volume":"81","author":"SJ Nicholls","year":"2023","unstructured":"Nicholls SJ. PCSK9 inhibitors and reduction in cardiovascular events: current evidence and future perspectives. Kardiol Pol. 2023;81:115\u201322. https:\/\/doi.org\/10.33963\/KP.a2023.0030.","journal-title":"Kardiol Pol"},{"key":"5518_CR37","doi-asserted-by":"publisher","first-page":"e24334","DOI":"10.1002\/clc.24334","volume":"47","author":"H Soleimani","year":"2024","unstructured":"Soleimani H, Mousavi A, Shojaei S, Tavakoli K, Salabat D, Farahani Rad F, et al. Safety and effectiveness of high-intensity Statins versus low\/moderate-intensity Statins plus Ezetimibe in patients with atherosclerotic cardiovascular disease for reaching LDL-C goals: a systematic review and meta-analysis. Clin Cardiol. 2024;47:e24334. https:\/\/doi.org\/10.1002\/clc.24334.","journal-title":"Clin Cardiol"},{"key":"5518_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11883-024-01265-9","volume":"27","author":"RD Paparodis","year":"2025","unstructured":"Paparodis RD, Bantouna D, Livadas S, Angelopoulos N. Statin therapy in primary and secondary cardiovascular disease prevention. Curr Atheroscler Rep. 2025;27:21\u201332. https:\/\/doi.org\/10.1007\/s11883-024-01265-9.","journal-title":"Curr Atheroscler Rep"},{"key":"5518_CR39","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to Statin therapy after acute coronary syndromes. N Engl J Med. 2015;372:2387\u201397. https:\/\/doi.org\/10.1056\/NEJMoa1410489.","journal-title":"N Engl J Med"},{"key":"5518_CR40","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ekir.2023.05.008","volume":"8","author":"WG Herrington","year":"2023","unstructured":"Herrington WG, Harper C, Staplin N, Haynes R, Emberson J, Reith C, et al. Impact of outcome adjudication in kidney disease trials: observations from the study of heart and renal protection (SHARP). Kidney Int Rep. 2023;8:1489\u201395. https:\/\/doi.org\/10.1016\/j.ekir.2023.05.008.","journal-title":"Kidney Int Rep"},{"key":"5518_CR41","doi-asserted-by":"publisher","first-page":"117560","DOI":"10.1016\/j.atherosclerosis.2024.117560","volume":"394","author":"A Dardano","year":"2024","unstructured":"Dardano A, Bianchi C, Garofolo M, Del Prato S. The current landscape for diabetes treatment: preventing diabetes-associated CV risk. Atherosclerosis. 2024;394:117560. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117560.","journal-title":"Atherosclerosis"},{"key":"5518_CR42","doi-asserted-by":"publisher","first-page":"1227769","DOI":"10.3389\/fcvm.2023.1227769","volume":"10","author":"P Gourdy","year":"2023","unstructured":"Gourdy P, Schiele F, Halimi J-M, Kownator S, Hadjadj S, Valensi P. Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines. Front Cardiovasc Med. 2023;10:1227769. https:\/\/doi.org\/10.3389\/fcvm.2023.1227769.","journal-title":"Front Cardiovasc Med"},{"key":"5518_CR43","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00125-021-05637-7","volume":"65","author":"KL Ho","year":"2022","unstructured":"Ho KL, Karwi QG, Connolly D, Pherwani S, Ketema EB, Ussher JR, et al. Metabolic, structural and biochemical changes in diabetes and the development of heart failure. Diabetologia. 2022;65:411\u201323. https:\/\/doi.org\/10.1007\/s00125-021-05637-7.","journal-title":"Diabetologia"},{"key":"5518_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12933-024-02435-4","volume":"23","author":"L Jiang","year":"2024","unstructured":"Jiang L, Xu H, Li Y, Shi K, Fang H, Yan W, et al. The differential effects of dyslipidemia status and triglyceride-glucose index on left ventricular global function and myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance study. Cardiovasc Diabetol. 2024;23:345\u201356. https:\/\/doi.org\/10.1186\/s12933-024-02435-4.","journal-title":"Cardiovasc Diabetol"},{"key":"5518_CR45","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.21037\/qims-24-1668","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Sun L, Zhao X-X. Value of high-density lipoprotein cholesterol, myocardial perfusion index, and global longitudinal strain derived from cardiac magnetic resonance imaging in predicting coronary slow flow in patients with nonobstructive coronary artery disease. Quant Imaging Med Surg. 2025;15:8491\u2013504. https:\/\/doi.org\/10.21037\/qims-24-1668.","journal-title":"Quant Imaging Med Surg"},{"key":"5518_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","volume":"18","author":"D Tomic","year":"2022","unstructured":"Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18:525\u201339. https:\/\/doi.org\/10.1038\/s41574-022-00690-7.","journal-title":"Nat Rev Endocrinol"},{"key":"5518_CR47","doi-asserted-by":"publisher","unstructured":"Seferovi\u0107 PM, Paulus WJ, Rosano G, Polovina M, Petrie MC, Jhund PS, et al. Diabetic myocardial disorder. A clinical consensus statement of the heart failure association of the ESC and the ESC working group on myocardial & pericardial diseases. Eur J Heart Fail. 2024;ejhf3347. https:\/\/doi.org\/10.1002\/ejhf.3347.","DOI":"10.1002\/ejhf.3347"},{"key":"5518_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41387-024-00318-x","volume":"14","author":"Z Lin","year":"2024","unstructured":"Lin Z, He J, Yuan S, Song C, Bian X, Yang M, et al. Hemoglobin glycation index and cardiovascular outcomes in patients with diabetes and coronary artery disease: insights from a large cohort study. Nutr Diabetes. 2024;14:69. https:\/\/doi.org\/10.1038\/s41387-024-00318-x.","journal-title":"Nutr Diabetes"},{"key":"5518_CR49","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12944-025-02707-2","volume":"24","author":"J Huang","year":"2025","unstructured":"Huang J, Zhang J, Xie Z, Li L, Chen M, Li Y, et al. Integrated metabolic-inflammatory risk assessment: HbA1c\/HDL-c and hsCRP-to-albumin ratios synergistically predict major adverse cardiovascular events in post-PCI STEMI patients. Lipids Health Dis. 2025;24:280. https:\/\/doi.org\/10.1186\/s12944-025-02707-2.","journal-title":"Lipids Health Dis"},{"key":"5518_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12872-023-03082-5","volume":"23","author":"Z Li","year":"2023","unstructured":"Li Z, Han D, Qi T, Deng J, Li L, Gao C, et al. Hemoglobin A1c in type 2 diabetes mellitus patients with preserved ejection fraction is an independent predictor of left ventricular myocardial deformation and tissue abnormalities. BMC Cardiovasc Disord. 2023;23:49. https:\/\/doi.org\/10.1186\/s12872-023-03082-5.","journal-title":"BMC Cardiovasc Disord"},{"key":"5518_CR51","doi-asserted-by":"publisher","first-page":"111884","DOI":"10.1016\/j.diabres.2024.111884","volume":"217","author":"B Liu","year":"2024","unstructured":"Liu B, Li L, Cui H, Zhao Q, Chen S. Analysis of the global burden of CKD-T2DM in young and middle-aged adults in 204 countries and territories from 2000 to 2019: a systematic study of the global burden of disease in 2019. Diabetes Res Clin Pract. 2024;217:111884. https:\/\/doi.org\/10.1016\/j.diabres.2024.111884.","journal-title":"Diabetes Res Clin Pract"},{"key":"5518_CR52","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.2337\/dc25-0355","volume":"48","author":"J Cho","year":"2025","unstructured":"Cho J, Woo S, Hwang SH, Kim S, Lee H, Hwang J, et al. A multimodal predictive model for chronic kidney disease and its association with vascular complications in patients with type 2 diabetes: model development and validation study in South Korea and the U.K. Diabetes Care. 2025;48:1562\u201370. https:\/\/doi.org\/10.2337\/dc25-0355.","journal-title":"Diabetes Care"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05518-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05518-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05518-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:51:12Z","timestamp":1770724272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05518-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5518"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05518-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the Declaration of Helsinki and was approved by Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (Approval No.[2024-K0512]). Informed consent was waived by the same committee for this retrospective study. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}